|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2002-10-1
|
|
pubmed:abstractText |
The objective of the present study was to evaluate the therapeutic efficacy of ciliary neurotrophic factor (CNTF) delivered through encapsulated cells directly into the vitreous of the eye in an rcd1 canine model of retinitis pigmentosa. The dose-range effect of the treatment was also investigated.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0146-0404
|
|
pubmed:author |
pubmed-author:AclandGregory MGM,
pubmed-author:AguirreGustavo DGD,
pubmed-author:BellWilliam JWJ,
pubmed-author:BudzVeronica AVA,
pubmed-author:DeanBrenda JBJ,
pubmed-author:GoddardMoses BMB,
pubmed-author:KauperKonrad AKA,
pubmed-author:LatiesAlan MAM,
pubmed-author:O'RourkePam JPJ,
pubmed-author:Pearce-KellingSueS,
pubmed-author:SCALJ CJC,
pubmed-author:ShermanSandy DSD,
pubmed-author:StabilaPaul FPF,
pubmed-author:TaoWengW,
pubmed-author:TsiarasWilliam GWG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3292-8
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12356837-Animals,
pubmed-meshheading:12356837-Animals, Genetically Modified,
pubmed-meshheading:12356837-Cell Line,
pubmed-meshheading:12356837-Ciliary Neurotrophic Factor,
pubmed-meshheading:12356837-Delayed-Action Preparations,
pubmed-meshheading:12356837-Dogs,
pubmed-meshheading:12356837-Dose-Response Relationship, Drug,
pubmed-meshheading:12356837-Drug Delivery Systems,
pubmed-meshheading:12356837-Equipment Design,
pubmed-meshheading:12356837-Humans,
pubmed-meshheading:12356837-Nerve Degeneration,
pubmed-meshheading:12356837-Neuroprotective Agents,
pubmed-meshheading:12356837-Photoreceptor Cells,
pubmed-meshheading:12356837-Rats,
pubmed-meshheading:12356837-Retinitis Pigmentosa
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.
|
|
pubmed:affiliation |
Neurotech USA, Lincoln, Rhode Island 02865, USA. w.tao@neurotech.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
